Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2581-2589

  Krusenstjerna Hafstrøm, Thomas ^a   Vestergaard, Esben Thyssen ^a   Buhl, Mads ^a   Nielsen, Roni ^a   Clasen, Berthil F ^a   Nielsen, Søren ^a   Møller, Niels ^a   Pedersen, Steen B ^a   Jørgensen, Jens Otto Lunde ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; MESSENGER RNA; SODIUM CHLORIDE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN 14; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTERIAL BLOOD; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMORAL ARTERY; FEMORAL VEIN; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; MALE; METABOLISM; MUSCLE BIOPSY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; VENOUS BLOOD;

ADULT; BIOPSY; BLOOD GLUCOSE; C-PEPTIDE; GENE EXPRESSION; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GTPASE-ACTIVATING PROTEINS; HUMAN GROWTH HORMONE; HUMANS; HYPERINSULINISM; INFUSIONS, INTRA-ARTERIAL; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEG; LIPIDS; MALE; MUSCLE, SKELETAL; SOMATOSTATIN; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; YOUNG ADULT;

EID: 79961244794     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0592     Document Type: Article

References (27)

1. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99:789-798 (Pubitemid 27097683)
2. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S 1997 Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest 100:2386-2392 (Pubitemid 27500164)
3. Carmichael JD, Bonert VS, Mirocha JM, Melmed S 2009 The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 94:523-527
4. Rubeck KZ, Madsen M, Andreasen CM, Fisker S, Frystyk J, Jørgensen JO 2010 Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery. Eur J Endocrinol 163:717-726
5. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74 (Pubitemid 32187803)
6. Murray RD, Kim K, Ren SG, Chelly M, Umehara Y, Melmed S 2004 Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. J Clin Invest 114:349-356 (Pubitemid 39071607)
7. Ambler GR, Butler AA, Padmanabhan J, Breier BH, Gluckman PD 1996 The effects of octreotide on GH receptor and IGF-I expression in the GH-deficient rat. J Endocrinol 149:223-231 (Pubitemid 26173534)
8. Møller N, Jørgensen JO 2009 Effects of growth hormone on glucose,lipid, and protein metabolism in human subjects. Endocr Rev 30:152-177
9. Møller N, Bagger JP, Schmitz O, Jørgensen JO, Ovesen P, Møller J, Alberti KG, Orskov H 1995 Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm. J Clin Endocrinol Metab 80:1789-1793
10. Vestergaard ET, Buhl M, Gjedsted J, Madsen M, Jessen N, Nielsen S, Gaylinn BD, Liu J, Thorner MO, Moller N, Jorgensen JO 2011 Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. J Clin Endocrinol Metab 96:468-477
11. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223 (Pubitemid 9249478)
12. Wojtaszewski JF, Hansen BF, Ursø B, Richter EA 1996 Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol 81:1501-1509 (Pubitemid 26349599)
13. Jørgensen JO, Jessen N, Pedersen SB, Vestergaard E, Gormsen L, Lund SA, Billestrup N 2006 GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am J Physiol Endocrinol Metab 291:E899-E905
14. Jessen N, Selmer Buhl E, Pold R, Schmitz O, Lund S 2008 A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles. Horm Metab Res 40:269-275 (Pubitemid 351533110)
15. Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF 2008 Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57:357-366
16. Treebak JT, Birk JB, Rose AJ, Kiens B, Richter EA, Wojtaszewski JF 2007 AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscleduring exercise in humans. Am J Physiol Endocrinol Metab 292:E715-E722 (Pubitemid 46411048)
17. Orskov H, Thomsen HG, Yde H 1968 Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219:193-195
18. Guo Z, Nielsen S, Burguera B, Jensen MD 1997 Free fatty acid turnover measured using ultralow doses of [U-13C]palmitate. J Lipid Res 38:1888-1895 (Pubitemid 27411280)
19. Saltin B, Rådegran G, Koskolou MD, Roach RC 1998 Skeletal muscleblood flow in humans and its regulation during exercise. Acta Physiol Scand 162:421-436 (Pubitemid 28121421)
20. Møller N, Butler PC, Antsiferov MA, Alberti KG 1989 Effects ofgrowth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32:105-110 (Pubitemid 19096382)
21. Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Møller N, Lund S,Jørgensen JO 2008 Growth hormone signaling in vivo in humanmuscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93:2842-2850 (Pubitemid 352008560)
22. Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E 2006 Negative regulation of growth hormone receptor signaling. Mol Endocrinol 20:241-253 (Pubitemid 43152501)
23. Davey HW, McLachlan MJ, Wilkins RJ, Hilton DJ, Adams TE 1999 STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol Cell Endocrinol 158:111-116
24. Ridderstråle M, Amstrup J, Hilton DJ, Billestrup N, Tornqvist H 2003 SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Horm Metab Res 35:169-177 (Pubitemid 36577859)
25. Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, Laville M, Vidal H 2004 Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53:2232-2241 (Pubitemid 39145576)
26. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW 2001 Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276:25889-25893
27. Very NM, Sheridan MA 2007 Somatostatin regulates hepatic growth hormone sensitivity by internalizing growth hormone receptors and by decreasing transcription of growth hormone receptor mRNAs. Am J Physiol Regul Integr Comp Physiol 292:R1956-R1962 (Pubitemid 46708551)